Collegium Pharmaceutical, Inc. COLL Return on equity

Return on equity at other companies

AVN

AVNSAVNS

-9.2%-3.9pp

Pacira BioSciences, Inc.PCRX

0.7%—

BioventusBVS

28%+27.5pp

OrganonOGN

71.6%—

Dogwood TherapeuticsDWTX

-64.6%-29.8pp

Cumberland PharmaceuticalsCPIX

-48.1%-67.6pp

FAQ

What is Collegium Pharmaceutical, Inc.'s return on equity?

Collegium Pharmaceutical, Inc. (COLL) reported return on equity of 17.6% in Q2 2026.

How has Collegium Pharmaceutical, Inc.'s return on equity changed year-over-year?

Collegium Pharmaceutical, Inc.'s return on equity increased by 9.0% year-over-year, from 16.2% to 17.6%.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s return on equity?

Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s return on equity has grown at a 3.9% compound annual growth rate (CAGR), from 19.6% to 23.7%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.